1-propanol has been researched along with pentoxifylline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atteia, HH; Elnagar, GM; Elrashidy, RA; Elseweidy, MM; Mohamed, HE | 1 |
1 other study(ies) available for 1-propanol and pentoxifylline
Article | Year |
---|---|
Inhibition of Aortic Calcification by Policosanol in Dyslipidemic Rabbits Is Enhanced by Pentoxifylline: Potential Role of PCSK9.
Topics: Alkaline Phosphatase; Animals; Anticholesteremic Agents; Aorta; Aortic Diseases; Biomarkers; Bone Morphogenetic Protein 2; Disease Models, Animal; Drug Therapy, Combination; Dyslipidemias; Fatty Alcohols; Lipids; Male; Osteocalcin; Osteopontin; PCSK9 Inhibitors; Pentoxifylline; Proprotein Convertase 9; Rabbits; Serine Proteinase Inhibitors; Signal Transduction; Tumor Necrosis Factor-alpha; Vascular Calcification; Wnt3A Protein | 2018 |